NANOVI A/S: Financial statements 2013
CVR: 34889031
Source: annual report 2013, Danish Business Authority
12/12/2012 – 31/12/2013
NANOVI A/S (CVR 34889031) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -1,142,278 and a net result of DKK -1,851,144. Equity in the 2013 report amounted to DKK 2,688,692. The solvency ratio was 78.5%.
- Gross Profit
- DKK -1,142,278
- Profit/Loss
- DKK -1,851,144
- Equity
- DKK 2,688,692
- Total Assets
- DKK 3,427,069
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of September 16, 2013, Jesper Roested has joined the board of directors of NANOVI A/S.
As of September 16, 2013, Morten Albrechtsen is registered as adm. dir. of NANOVI A/S.
As of January 25, 2013, JUT NR. 2180 A/S has been appointed auditor of NANOVI A/S.
As of January 25, 2013, EY Danmark A/S has stepped down as auditor of NANOVI A/S.
As of January 2, 2013, Thomas Lars Andresen has joined the board of directors of NANOVI A/S.
About NANOVI A/S
NANOVI A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2012. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company was previously named NANOVI RADIOTHERAPY A/S and NANOVI RADIOTHERAPY ApS. The management consists of Michael Todd Galbus. The board consists of Percy Charwood Tomlinson Jr (chair), Jesper Boysen and Michael Todd Galbus. The company is owned by Sinmed Holding International B.V.. The company has 1 employee (2024). In 2025, the company reported revenue of DKK 90,321 and a net result of DKK -804,274 compared with DKK -612,100 the year before. Equity in the 2025 report amounted to DKK 560,746.